Shopping Cart
Remove All
Your shopping cart is currently empty
Coumetarol (Dicumoxane) is a vitamin K antagonist and an oral anticoagulant that can be used to study arterial thrombotic occlusion.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $49 | - | In Stock | |
| 5 mg | Preferential | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $149 | - | In Stock |
| Description | Coumetarol (Dicumoxane) is a vitamin K antagonist and an oral anticoagulant that can be used to study arterial thrombotic occlusion. |
| In vitro | The vitamin K antagonist Coumetarol (Dicumoxane) is effective in both models after oral treatment but inhibits thrombus formation more strongly in the arterio-venous shunt model. Treatment with Coumetarol in a dose of 25 mg/kg p.o. twice daily for 2 days results in a significant reduction in thrombus weight by 50% in the venous stasis model and by 75% in the arterio-venous shunt model. In both experiments, the coagulation time as measured by the Thrombotest is prolonged to the same extent. |
| In vivo | The vitamin K antagonist Coumetarol showed efficacy in both models after oral treatment, particularly demonstrating stronger thrombotic inhibition in the arteriolar junction model. Coumetarol was administered orally at a therapeutic dose of 25 mg/kg. Twice-daily administration for two consecutive days resulted in a significant 50% reduction in thrombus weight in the venous pause model and a significant 75% reduction in the arterial cleft shunt model. [1] |
| Synonyms | Ph 137, Dicumoxane |
| Molecular Weight | 380.35 |
| Formula | C21H16O7 |
| Cas No. | 4366-18-1 |
| Smiles | O=C1OC=2C=CC=CC2C(O)=C1C(C=3C(=O)OC=4C=CC=CC4C3O)COC |
| Relative Density. | 1.514 g/cm3 (Predicted) |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 180 mg/mL (473.25 mM.), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (10.52 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.